Santen Pharmaceutical

Apr 01, 2020

Santen Inc. Announces Appointment of Tatsuya Kaihara as Corporate Officer and Head of North America Business of Santen Pharmaceutical

Jan 10, 2020

Global Dry Eye Disease Industry Outlook to 2025; Led by Novartis, Allergan, Johnson & Johnson Vision Care, Santen Pharmaceutical, and Bausch Health Companies

Sep 18, 2019

Santen Pharmaceutical Establishes a Safety Database With ArisGlobal's LifeSphere® MultiVigilance Multi-tenant Drug Safety Suite to Improve and Streamline Pharmacovigilance at a Global Scale

May 22, 2019

NTC Grants Further License and Distribution Rights to Santen for Its Fixed Combination Dexamethasone With Levofloxacin in South East Asia

Mar 08, 2019

Santen to Conduct Activities to Raise Disease Awareness during World Glaucoma Week, March 10 to 16

Nov 15, 2018

Santen Expands Research and Development Leadership Team with Additions of Reza M. Haque, MD, PhD and Peter Sallstig, MD, MBA

Nov 28, 2017

The global ophthalmic therapeutics/drugs market is expected to reach USD 35.7 billion by 2025

Nov 24, 2017

Global Ophthalmic Therapeutics/Drug Market 2014-2017 & Forecasts to 2025 - Market is Expected to Reach USD 35.7 Billion

Nov 15, 2017

Global Ophthalmic Drugs Market Expected to Reach $42,663 Million by 2023 - Allied Market Research